TY  - CONF

T1  - AZD5363, AN AKT INHIBITOR, SIGNIFICANTLY INHIBITS KEY BIOMARKERS OF THE AKT PATHWAY AND KI67, IN A RANDOMIZED, PLACEBO, CONTROLLED STUDY (STAKT) IN HUMAN BREAST CANCERS

JO  - BRITISH JOURNAL OF SURGERY

PY  - 2018/01/01

AU  - Robertson JFR

AU  - Coleman RE

AU  - Cheung KL

AU  - Evans A

AU  - Holcombe C

AU  - Skene A

AU  - Rea D

AU  - Ahmed S

AU  - Jahan A

AU  - Kelly S

AU  - Horgan K et al

ED  - 

VL  - 105

SP  - 24

EP  - 24

Y2  - 2025/10/10

ER  -